Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

Rhea-AI Summary

Compass Therapeutics, Inc. (CMPX) will participate in the Leerink Partners Global Biopharma Conference on March 13, 2024, to showcase its antibody-based therapeutics for human diseases.

BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the Leerink Partners Global Biopharma Conference in Miami Beach, Florida on Wednesday, March 13, 2024.

Fireside Chat details
Date: Wednesday, March 13, 2024
Time: 10:40 AM ET
Webcast Link: https://wsw.com/webcast/

Virtual/Replay availability: The corporate presentation will be archived for 90 days on Compass’ Events page.

About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass’s pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. Compass was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics, Inc. website at www.compasstherapeutics.com.

Investor Contact
ir@compasstherapeutics.com

Media Contact
Anna Gifford, Senior Manager of Communications
media@compasstherapeutics.com
617-500-8099

When will Compass Therapeutics participate in the Leerink Partners Global Biopharma Conference?

Compass Therapeutics will participate in the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024.

What is the focus of Compass Therapeutics as a company?

Compass Therapeutics focuses on developing proprietary antibody-based therapeutics to treat multiple human diseases.

Where will the conference take place?

The conference will be held in Miami Beach, Florida.

Is the corporate presentation available for replay?

Yes, the corporate presentation will be archived for 90 days on Compass' Events page.